Is imipramine approved for anxiety, and when do doctors use it anyway?
Imipramine is a tricyclic antidepressant (TCA). It is primarily approved and used for depression, but some clinicians prescribe it off-label for anxiety disorders when other options are not suitable. TCAs can be considered when symptoms are persistent and when sedation is helpful, but they also come with more side effects and safety concerns than newer antidepressants in many patients.
Because the question is specifically “imipramine for anxiety,” it’s useful to clarify what diagnosis is being treated (for example, generalized anxiety disorder, panic disorder, or anxiety related to depression). Different anxiety conditions have different first-line treatments.
What kinds of anxiety might respond to imipramine?
In practice, TCAs have sometimes been used for anxiety syndromes that co-occur with depression or involve prominent panic or persistent worry. Imipramine’s effects are not the same as benzodiazepines (which act quickly on GABA receptors), so symptom improvement may take time and usually parallels antidepressant onset patterns.
If the anxiety is primarily panic or generalized worry, many clinicians first try other medication classes (such as SSRIs/SNRIs) because they tend to be easier to use safely. Still, imipramine may be chosen when comorbid depression is present or when an individual has responded to a TCA before.
How long does it take to work for anxiety?
With antidepressant-style medications like imipramine, early effects (like sleep improvement) can appear within days, but noticeable anxiety relief often takes longer, commonly a few weeks. The exact timeline depends on dose, symptom pattern, and how quickly side effects limit the ability to increase dose.
What side effects are most concerning with imipramine?
TCAs can cause side effects that matter a lot for anxiety patients, especially if they are also dealing with insomnia, autonomic symptoms, or sensitivity to sedation. Common issues include dry mouth, constipation, blurred vision, urinary retention, weight gain, and drowsiness. Imipramine can also affect heart rhythm and blood pressure, which is why clinicians are careful about cardiac history and, in some cases, heart monitoring.
If someone is taking other medications that also affect heart rhythm or sedation (including some antihistamines and other psychotropics), the interaction risk goes up.
What about risks with overdose or combining with other drugs?
TCAs are riskier in overdose than many other anxiety and antidepressant options. That risk is relevant for patient safety planning, especially in anyone with a history of self-harm or impulsivity. Mixing imipramine with alcohol or other sedating medications can also lead to dangerous sedation and impaired breathing.
Is imipramine safer than benzodiazepines for anxiety?
They’re different treatments. Benzodiazepines can reduce anxiety quickly, but they have risks like dependence, tolerance, and withdrawal. Imipramine does not carry benzodiazepine dependence/withdrawal in the same way, but it has its own safety concerns (notably anticholinergic effects and potential cardiac effects). For many people, clinicians use SSRIs/SNRIs as a balance of efficacy and long-term safety rather than choosing a TCA.
What do patients usually ask: can it help sleep and nighttime anxiety?
Yes. One reason some clinicians try imipramine in anxious patients is that it can be sedating, which may help when anxiety disrupts sleep. The trade-off is daytime drowsiness, especially at the start or after dose changes.
Alternatives if imipramine is not a good fit
If imipramine isn’t tolerated or is too risky, common alternatives depend on the specific anxiety disorder and comorbidities. Many treatment pathways start with SSRIs or SNRIs, sometimes with short-term “bridge” strategies while longer-term medication takes effect. Therapy (especially CBT) is also often recommended alongside or instead of medication.
Sources
No sources were provided in the prompt. If you want, share what country you’re in and which anxiety diagnosis you mean (e.g., GAD vs panic disorder), and I can tailor the answer to typical clinical use and safety checks.